These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16023782)

  • 1. Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy.
    Shunchang S; Fan Q; Huacheng W; Leturcq F; Yongjian S; Bingfeng Z; Wen Y; Deburgrave N
    Clin Neurol Neurosurg; 2006 Jun; 108(4):369-73. PubMed ID: 16023782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysferlin deficiency: the cause of limb-girdle muscular dystrophy 2B and Miyoshi myopathy in a Chinese pedigree].
    Sun S; Fan Q; Wu H; Leturcq F; Zhang B; Yu W; Deburgrave N; Liu M; Song Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):128-31. PubMed ID: 15079794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic features and genetic findings in 2 chinese families with Miyoshi distal myopathy.
    Ro LS; Lee-Chen GJ; Lin TC; Wu YR; Chen CM; Lin CY; Chen ST
    Arch Neurol; 2004 Oct; 61(10):1594-9. PubMed ID: 15477515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ueyama H; Kumamoto T; Nagao S; Masuda T; Horinouchi H; Fujimoto S; Tsuda T
    Neuromuscul Disord; 2001 Mar; 11(2):139-45. PubMed ID: 11257469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for the genetic screening in dysferlin deficiency--report of an instructive case and review of the literature.
    Gal A; Siska E; Nagy Z; Karpati G; Molnar MJ
    Clin Neuropathol; 2008; 27(5):289-94. PubMed ID: 18808059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene.
    Nakagawa M; Matsuzaki T; Suehara M; Kanzato N; Takashima H; Higuchi I; Matsumura T; Goto K; Arahata K; Osame M
    J Neurol Sci; 2001 Feb; 184(1):15-9. PubMed ID: 11231027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
    Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
    Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.
    McNally EM; Ly CT; Rosenmann H; Mitrani Rosenbaum S; Jiang W; Anderson LV; Soffer D; Argov Z
    Am J Med Genet; 2000 Apr; 91(4):305-12. PubMed ID: 10766988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, de novo dysferlin gene mutations in a patient with Miyoshi myopathy.
    Hu YY; Lian YJ; Xu HL; Zheng YK; Li CF; Zhang JW; Yan SP
    Neurosci Lett; 2018 Jan; 664():107-109. PubMed ID: 29138090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel compound heterozygous dysferlin mutation in Miyoshi myopathy siblings responding to dantrolene.
    Hattori H; Nagata E; Oya Y; Takahashi T; Aoki M; Ito D; Suzuki N
    Eur J Neurol; 2007 Nov; 14(11):1288-91. PubMed ID: 17868276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.
    Xi J; Blandin G; Lu J; Luo S; Zhu W; Béroud C; Pécheux C; Labelle V; Lévy N; Urtizberea JA; Zhao C; Krahn M
    Neurol India; 2014; 62(6):635-9. PubMed ID: 25591676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.